Brief: Crossject FY Operating Loss Widens To EUR 10.7 Mln
30/03/2021 07:31
March 30 (Reuters) - CROSSJECT SA ALCJ.PA :
* ANNOUNCED ON MONDAY FY RESULTS
* NO FY REVENUES VS EUR 0.5 MLN YR AGO
* FY OPERATING LOSS EUR 10.7 MLN VS LOSS EUR 8.6 MLN YR AGO
* FY NET LOSS EUR 9.8 MLN VS EUR 7.2 MLN YR AGO
* INTENDS TO KEEP SIGNING NEW PARTNERSHIPS IN US AND EUROPE
Source text for Eikon: ID:nGNE60THjw
Further company coverage: ALCJ.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))
Recent news on Crossject SA
See all newsBrief: Crossject Says Expects To File For EUA Early Next Year For Epilepsy Rescue Therapy Zepizure
Brief: Crossject Signs A Geographic Extension Of Zepizure Commercialization Agreement In Europe
Brief: Crossject FY Operating Income Up At EUR 12.82 Mln
Brief: Crossject Announces Contract Of Up To $155 Mln With BARDA
Brief: Crossject Engages Syneos Health For U.S. Commercial Launch Of Zepizure